Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout

Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout

Bibliographic Details
Main Authors:	Batt, Caitlin, Phipps-Green, Amanda J, Black, Michael A, Cadzow, Murray, Merriman, Marilyn E, Topless, Ruth, Gow, Peter, Harrison, Andrew, Highton, John, Jones, Peter, Stamp, Lisa, Dalbeth, Nicola, Merriman, Tony R
Format:	Online
Language:	English
Published:	BMJ Publishing Group 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251167/

Similar Items

Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout
by: Dalbeth, Nicola, et al.
Published: (2015)

Sugar Sweetened Beverage Consumption among Adults with Gout or Type 2 Diabetes
by: Murphy, Rinki, et al.
Published: (2015)

The relationship between ferritin and urate levels and risk of gout
by: Tahzeeb Fatima, et al.
Published: (2018-08-01)

Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge
by: Dalbeth, Nicola, et al.
Published: (2014)

The renal urate transporter SLC17A1 locus: confirmation of association with gout
by: Hollis-Moffatt, Jade E, et al.
Published: (2012)

Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects
by: Flynn, Tanya J, et al.
Published: (2013)

Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares
by: Flynn, Tanya J, et al.
Published: (2015)

Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank
by: Murray Cadzow, et al.
Published: (2017-08-01)

Association of SLC2A9 genotype with phenotypic variability of serum urate in pre-menopausal women
by: Topless, Ruth K., et al.
Published: (2015)

The genetics of gout: towards personalised medicine?
by: Nicola Dalbeth, et al.
Published: (2017-05-01)

The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity
by: Hollis-Moffatt, Jade E, et al.
Published: (2011)

Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout
by: Humaira Rasheed, et al.
Published: (2017-07-01)

Mediation analysis to understand genetic relationships between habitual coffee intake and gout
by: Joseph Hutton, et al.
Published: (2018-07-01)

An update on the genetic architecture of hyperuricemia and gout
by: Merriman, Tony R
Published: (2015)

The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout
by: Rasheed, Humaira, et al.
Published: (2014)

Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
by: Mengying Sun, et al.
Published: (2018-05-01)

Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout
by: McKinney, Cushla, et al.
Published: (2015)

Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption
by: Rasheed, Humaira, et al.
Published: (2013)

Urate crystal deposition and bone erosion in gout: ‘inside-out’ or ‘outside-in’? A dual-energy computed tomography study
by: Towiwat, Patapong, et al.
Published: (2016)

Monosodium urate crystal deposits are common in asymptomatic sons of people with gout: The Sons of gout study
by: Abhishek, Abhishek, et al.
Published: (2018)

The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden
by: Meliha C. Kapetanovic, et al.
Published: (2018-08-01)

Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England
by: Kuo, Chang-Fu, et al.
Published: (2014)

The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
by: Jackson, Robert L, et al.
Published: (2012)

Effect of Fenofibrate in Combination with Urate Lowering Agents in Patients with Gout
by: Lee, You-Hyun, et al.
Published: (2006)

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
by: Dalbeth, Nicola, et al.
Published: (2012)

On the Nature and Treatment of Gout and Rheumatic Gout
Published: (1864)

The Nature and Treatment of Gout and Rheumatic Gout
Published: (1860)

Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis
by: Morillon, Melanie B, et al.
Published: (2016)

Gout
Published: (1895)

The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets
by: Rasheed, Humaira, et al.
Published: (2016)

Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout
by: Tan, Philip K., et al.
Published: (2016)

Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016)

Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease
by: Jiaojiao Jing, et al.
Published: (2018-09-01)

A Treatise on Gout, Rheumatism, and Rheumatic Gout
Published: (1873)

Spatiotemporal gait parameters and plantar pressure distribution during barefoot walking in people with gout and asymptomatic hyperuricemia: comparison with healthy individuals with normal serum urate concentrations
by: Stewart, Sarah, et al.
Published: (2016)

The first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia
by: Stewart, Sarah, et al.
Published: (2015)

Rheumatism and Gout
Published: (1901)

The Pathology of Gout
Published: (1906)

Rheumatism and Gout
Published: (1906)

Rheumatism and Gout
Published: (1905)